PD-L1 immunostaining scoring for non-small cell lung cancer based on immunosurveillance parameters

• Manuel A. Silva ,

  Roles Conceptualization, Investigation, Writing – original draft, Writing – review & editing

  * E-mail: manuel.silva@merckgroup.com

  Affiliation Department of Clinical Biomarkers and Companion Diagnostics, Merck KGaA, Darmstadt, Hessen, Germany

  http://orcid.org/0000-0002-3434-144X

  ⨯
• Karen A. Ryall,

  Roles Formal analysis, Writing – original draft

  Affiliation Department of Pathology, Flagship Biosciences, Inc., Westminster, Colorado, United States of America

  ⨯
• Claudia Wilm,

  Roles Methodology, Writing – original draft

  Affiliation Department of Clinical Biomarkers and Companion Diagnostics, Merck KGaA, Darmstadt, Hessen, Germany

  ⨯
• Jenifer Caldara,

  Roles Methodology, Software, Writing – original draft

  Affiliation Department of Pathology, Flagship Biosciences, Inc., Westminster, Colorado, United States of America

  ⨯
• Hans Juergen Grote,

  Roles Writing – review & editing

  Affiliation Department of Clinical Biomarkers and Companion Diagnostics, Merck KGaA, Darmstadt, Hessen, Germany

  ⨯
• Janet C. Patterson-Kane

  Roles Formal analysis, Methodology, Software, Writing – original draft, Writing – review & editing

  Affiliation Department of Pathology, Flagship Biosciences, Inc., Westminster, Colorado, United States of America

  ⨯